In short. How the choice between an implant and autologous fat transfer is made: the volume required, the tissue available, the coverage over it, and the very different risk profile of each route.

Key points

  • Fat transfer suits patients who want a modest increase, who have enough donor fat to harvest, and who accept that a proportion of what is injected will be reabsorbed and that some may need a second session.
  • An implant suits patients who want a larger or a more defined change, or who have very little donor fat.
  • Where the required volume is at the upper end, or the skin envelope is tight and thin, an implant is the operation that can actually deliver it.

There are two ways to add volume to a breast: place an implant, or take fat from elsewhere on the patient’s own body and graft it. Both work within limits, and the choice is made on anatomy rather than on preference. The commonest mistake is choosing before the assessment has happened.

What each route actually involves

An implant is a silicone elastomer shell, filled either with silicone gel or with saline, placed behind the gland or partly behind the pectoral muscle. It delivers a predictable volume in a single operation. Fat transfer is a two-part procedure: liposuction to harvest fat from the abdomen, flanks, or thighs, then purification and injection of that fat in small aliquots through many passes so that enough of it survives. There is no implant, no device to monitor, and no capsule — but the volume is far less predictable.

The volume question decides more than the preference

Fat transfer suits patients who want a modest increase, who have enough donor fat to harvest, and who accept that a proportion of what is injected will be reabsorbed and that some may need a second session. An implant suits patients who want a larger or a more defined change, or who have very little donor fat. Where the required volume is at the upper end, or the skin envelope is tight and thin, an implant is the operation that can actually deliver it. Deciding this from a photograph rather than from a measurement is how patients end up asking for an operation their tissues cannot support.

Where fat has the advantage

Fat transfer adds volume without a device, so it carries no capsular contracture and no implant rupture. It also improves the donor area as a side effect of harvest. Its specific risks are different rather than absent: a variable proportion of the grafted fat does not survive, cysts and calcifications can form and complicate the reading of future mammograms, and infection or fat necrosis occasionally requires intervention.

Where implants have the advantage

Implants offer control of volume and shape, a single operation, and a result that can be revised by exchanging the device. Their risks are the subject of their own guide on this site and are not small: capsular contracture, rupture, rippling and visibility in thin tissue, and a real likelihood of at least one further operation in the patient’s lifetime. An implant is a device with a lifespan, not a permanent feature of the body.

Either way, the same rule applies

Neither route is a single irreversible decision made in the abstract. Both should begin with measurements, a discussion of what the skin can cover, and a frank statement of what the patient will be living with in ten years — not only in ten weeks.

Ask before you choose a route

  • How much volume does my own tissue allow, and what happens if too little of the grafted fat survives?
  • What is the plan if an implant needs to be removed or exchanged — and who pays for that operation?
  • Will any of this interfere with how my mammograms are read, and how will that be monitored over time?

Related reading

Frequently asked questions

How is the choice between an implant and fat transfer made?

On anatomy rather than preference, and the volume required decides more than preference. Fat transfer suits a modest increase with enough donor fat, accepting that some is reabsorbed; an implant suits a larger or more defined change, or very little donor fat. Deciding from a photograph rather than a measurement is how patients ask for operations their tissues cannot support.

What are the advantages of fat transfer?

It adds volume without a device, so there is no capsular contracture and no implant rupture, and it improves the donor area as well. Its risks are different rather than absent: a variable proportion of the grafted fat does not survive, cysts and calcifications can form and complicate the reading of mammograms, and infection or fat necrosis occasionally requires intervention.

What are the disadvantages of an implant?

Capsular contracture, rupture, rippling and visibility in thin tissue, and a real likelihood of at least one further operation in the patient’s lifetime. An implant is a device with a lifespan, not a permanent feature of the body, and the plan for exchanging or removing it should be settled before the first operation.

Risks & Limitations

  • Breast implants are not lifetime devices: capsular contracture, rupture, rippling and malposition can occur and may need further surgery.
  • Seroma and other fluid collections, which may require drainage; seroma is a signature complication of abdominoplasty.
  • Wound-healing problems and widened or permanent scars.
  • Asymmetry and contour irregularities; perfect symmetry is not achievable.
  • Numbness or changed nipple and skin sensation, which may be temporary or permanent.
  • Venous thromboembolism (DVT/PE) risk after long procedures — prevention is part of the surgical plan.
  • Fat necrosis or contour irregularity after fat transfer; some of the transferred fat does not survive.
  • Liposuction is contouring, not weight loss, and does not prevent future weight regain.

When to Seek Care

  • Chest pain, shortness of breath or a swollen, painful calf — possible clot; seek emergency care immediately.
  • Fever, spreading redness, warmth or discharge from a wound.
  • A breast that becomes hard, painful or changes shape suddenly.
  • Severe abdominal pain, distension or vomiting after body surgery.
  • Bleeding or a rapidly expanding swelling at the operative site.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — breast surgery and safety guidance
  • International Society of Aesthetic Plastic Surgery (ISAPS)
  • U.S. Food and Drug Administration (FDA) — breast implant safety information
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.